https://www.selleckchem.com/TGF-beta.html
A reduction of 20% of vertebral body height was considered a VF. VCs were quantified by the length of calcific lesions along the arteries. The patients treated with oral calcitriol were 177 of 387 patients (45.7%). The prevalence of VF was lower in patients receiving oral calcitriol than in those untreated (48.6% versus 61.0%, p = 0.015), whereas the presence of aortic and iliac calcifications was similar (aortic 81.9% versus 79.5%, respectively, p = 0.552; iliac 52.0% and 59.5%, respectively, p = 0.167). In multivariable logistic regressio